Equifax
EFX
$166.44
-0.13%
Equifax is one of the three major U.S. credit bureaus, providing credit reports and data analytics to lenders, employers, and consumers. As a critical infrastructure provider in the financial system, it holds a duopoly-like position alongside Experian and TransUnion, with a growing Workforce Solutions segment that contributes about 40% of revenue. The current investor narrative centers on the company's ability to sustain mid-single-digit revenue growth amid a tightening mortgage market, while also navigating regulatory scrutiny and investing in AI-driven data products to differentiate from peers.…
EFX
Equifax
$166.44
Related headlines
EFX 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Equifax's 12-month outlook, with a consensus price target around $216.37 and implied upside of +30.0% versus the current price.
Average Target
$216.37
13 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
13
covering this stock
Price Range
$133 - $216
Analyst target range
Equifax is covered by 13 analysts, with a consensus leaning bullish: 8 Buy/Overweight ratings, 4 Hold/Neutral, and 0 Sell. The average price target is not explicitly provided, but based on the estimated EPS of $14.26 and a forward P/E of 16.2x, the implied target price is approximately $231 (16.2 * $14.26), representing 38.8% upside from the current price of $166.44. The consensus recommendation is Overweight, reflecting optimism about the earnings recovery. The target range is wide: the low EPS estimate of $13.68 implies a target of $222 (16.2x), while the high estimate of $15.04 implies $244, suggesting a spread of about 10%. This relatively tight range indicates strong conviction among analysts. Recent ratings from major firms (Goldman Sachs Neutral, RBC Outperform, Needham Buy, Barclays Equal Weight, Morgan Stanley Overweight, Stifel Buy, JP Morgan Overweight, Wells Fargo Overweight, Oppenheimer Outperform) show a predominantly bullish stance, with no downgrades in the past six months. The high target of $244 assumes successful execution on growth initiatives and margin expansion, while the low target of $222 prices in modest growth and stable margins. The wide spread in EPS estimates ($13.68–$15.04) reflects uncertainty around the pace of recovery, but the overall sentiment is positive.
Drowning in data?
Find the real signal!
EFX Technical Analysis
Equifax is in a sustained downtrend, with the stock down 37.2% over the past year, significantly underperforming the S&P 500's +20.6% gain. The current price of $166.44 sits at 61.2% of its 52-week range ($150.75–$271.84), indicating it is closer to the low end and reflecting persistent selling pressure. This positioning suggests the market is pricing in fundamental headwinds rather than a value opportunity, as the stock has failed to hold any meaningful support levels. Short-term momentum shows a conflicting picture: the 1-month change is +22.9%, a sharp bounce from the June lows near $152, while the 3-month change remains -6.5%. This divergence suggests a short-term relief rally within a longer-term downtrend, but the 1-month relative strength of -3.84% versus the S&P 500 indicates the bounce is lagging the broader market. The RSI is not provided, but the rapid 1-month gain could signal a temporary oversold bounce rather than a trend reversal. The 52-week low of $150.75 serves as critical support; a break below would open the door to further downside, while the 52-week high of $271.84 is a distant resistance. With a beta of 1.32, Equifax is 32% more volatile than the market, amplifying both downside risk and potential upside in a recovery scenario. The stock's current price is just 10.4% above the 52-week low, making the support level a key line in the sand for traders.
Beta
1.32
1.32x market volatility
Max Drawdown
-44.1%
Largest decline past year
52-Week Range
$151-$272
Price range past year
Annual Return
-37.2%
Cumulative gain past year
| Period | EFX Return | S&P 500 |
|---|---|---|
| 1m | +0.2% | +1.8% |
| 3m | -6.5% | +10.0% |
| 6m | -26.7% | +8.8% |
| 1y | -37.2% | +21.1% |
| ytd | -22.2% | +10.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
EFX Fundamental Analysis
Revenue has grown steadily, with Q4 2025 revenue of $1.55 billion, up 9.2% year-over-year, accelerating from 2.1% growth in Q4 2024. The trailing twelve-month revenue is approximately $6.07 billion, driven by the U.S. Consumer Information Solutions segment ($3.09 billion) and Workforce Solutions ($1.30 billion). However, the growth trajectory shows deceleration from the 10.5% YoY growth in Q2 2025, and the International segment ($725 million) remains a smaller contributor. The acceleration in Q4 2025 is encouraging, but sustainability is questionable given macro headwinds in mortgage and auto lending. Profitability is solid: net income for Q4 2025 was $175.7 million, with a net margin of 11.3%, though gross margin was just 10.96% due to a high cost of revenue ($1.38 billion). Operating margin improved to 18.3% in Q4 2025 from 16.2% in Q1 2025, indicating better cost control. However, the gross margin is unusually low for a data company, likely due to data acquisition costs, and is well below the industry average for information services (typically 50-60%). The balance sheet shows moderate leverage with a debt-to-equity ratio of 1.11 and a current ratio of 0.60, indicating liquidity risk. Free cash flow for the trailing twelve months is $1.13 billion, providing a healthy FCF yield of 4.2% at the current market cap. ROE is 14.3%, decent but not exceptional, and the company generated $470.8 million in operating cash flow in Q4 2025, covering capex of $130 million. The reliance on debt (total debt of ~$5.5 billion) and low cash balance ($180.8 million) make it vulnerable to rising interest rates, though the interest coverage ratio of 5.25x provides some cushion.
Quarterly Revenue
$1.6B
2025-12
Revenue YoY Growth
+9.24%
YoY Comparison
Gross Margin
10.96%
Latest Quarter
Free Cash Flow
$1.1B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is EFX Overvalued?
Since net income is positive, the primary valuation metric is the P/E ratio. The trailing P/E is 40.5x, while the forward P/E is 16.2x, implying the market expects significant earnings growth in the next year. The wide gap between trailing and forward P/E suggests that the current earnings are depressed (likely due to one-time charges or cyclical weakness), and the market is pricing in a recovery. Based on analyst estimates, the forward P/E of 16.2x is reasonable for a company with expected EPS growth of ~150% (from $1.45 in Q4 2025 to an estimated $14.26 for fiscal 2026). Compared to the industry average P/E of 22x for consulting services, Equifax's trailing P/E of 40.5x is an 84% premium, but the forward P/E of 16.2x is a 26% discount, reflecting the anticipated earnings rebound. The premium on trailing earnings is not justified by current profitability, but the forward discount could be attractive if the growth materializes. Historically, Equifax's trailing P/E has ranged from 27x to 73x over the past five years, with the current 40.5x near the middle of that range. The P/B ratio of 5.8x is at the lower end of its historical range (5.2x–10.0x), suggesting the stock is not overvalued on a book basis. The EV/EBITDA of 17.3x is also below the historical average of ~20x, indicating potential value if EBITDA growth resumes.
PE
40.5x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 27x~73x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
17.3x
Enterprise Value Multiple

